Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint

Area of Science:

• Clinical Trials
• Biostatistics
• Pharmacoeconomics

Background:

• The development of new therapeutics increasingly balances efficacy with patient-centered factors like reduced side effects and improved delivery.
• Noninferiority (NI) trials are crucial for evaluating treatments that may offer advantages over established options, even if slightly less efficacious.
• Traditional 3-arm NI trial designs often use indirect methods for setting noninferiority margins.

Purpose of the Study:

• To implement and evaluate a Bayesian approach for 3-arm noninferiority trials with binary outcomes.
• To explore the integration of historical trial data with current trial information through sequential learning within the Bayesian framework.
• To assess the feasibility of Bayesian methods for NI trials using approximation-based and exact fully Bayesian techniques.

Main Methods:

• The study proposes a Bayesian framework for analyzing 3-arm noninferiority trials.
• It utilizes several approximation-based methods and two exact fully Bayesian methods.
• The primary outcome of interest is binary.

Main Results:

• The proposed Bayesian methods are evaluated for feasibility in NI trial design.
• The approach allows for the integration of prior information, enabling sequential learning.
• A reanalysis of a clinical trial example demonstrates the practical benefits of the Bayesian approach.

Conclusions:

• The Bayesian implementation offers a flexible and powerful alternative for designing and analyzing noninferiority trials with binary outcomes.
• This approach facilitates the incorporation of historical data, enhancing the learning process across trials.
• The study highlights the potential of Bayesian methods to optimize the evaluation of new treatments considering multiple clinical factors.